← Leaderboards
Bin Liu
Venatorx Pharmaceuticals, Inc.
$3,147,000
Attributed
$3,294,000
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2012–24$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,294,000 · 2
By mechanism
R44$3,000,000 · 1
R43$294,000 · 1
Top collaborators
- Luigi Xerri1 shared
Most similar at Venatorx Pharmaceuticals, Inc.
Same institution · by research overlap
- Luigi Xerri$39,662,982
- Steven Armen Boyd$13,685,544
- Guo-Hua Chu$599,200
- Tsuyoshi Uehara$2,000,000
- Randy Jackson$150,000
Others in their field
Top investigators on “Resistance”
- Judith S. Currier · University Of California Los Angeles$243,611,225
- Gregory H Reaman · National Childhood Cancer Foundation$217,720,574
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$180,092,958
- Ralph Parchment · Leidos Biomedical Research, Inc.$149,556,948
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,991,858
- Peter C Adamson · National Childhood Cancer Foundation$113,790,601
Research focus
ResistanceAntibioticsLeadPseudomonas AeruginosaSmall Business Innovation Research GrantSuccessHospitalsInfectionMedicalPseudomonasEnzymesSeriesApplications GrantsCytotoxicityBacteriaFamilyChemistryCarbapenemsBeta-LactamaseLead SeriesPre-ClinicalCellsDoseBinding Proteins
Grant awards (4)
Broad spectrum β-lactamase inhibitors employing a Trojan horse mechanism to rescue β-lactams against multidrug-resistant Pseudomonas aeruginosa$1,000,000
R44 · FY2024 · AI · contact PI
Broad spectrum β-lactamase inhibitors employing a Trojan horse mechanism to rescue β-lactams against multidrug-resistant Pseudomonas aeruginosa$1,000,000
R44 · FY2023 · AI · contact PI
Broad spectrum β-lactamase inhibitors employing a Trojan horse mechanism to rescue β-lactams against multidrug-resistant Pseudomonas aeruginosa$1,000,000
R44 · FY2022 · AI · contact PI
Novel Metallo-beta-lactamase Inhibitors$294,000
R43 · FY2012 · AI